{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:58:40Z","timestamp":1791845920193,"version":"4.3.4"},"reference-count":32,"publisher":"S. Karger AG","issue":"5","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncology"],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Objectives:&lt;\/i&gt;&lt;\/b&gt; Gender-related aspects have been investigated in a variety of tumor entities including results on sex-specific differences in non-Hodgkin lymphoma. However, there are no data on gender differences in mucosa-associated lymphoid tissue (MALT) lymphoma. &lt;b&gt;&lt;i&gt;Methods:&lt;\/i&gt;&lt;\/b&gt; We have analyzed 327 patients treated between 1999 and 2015 with a median follow-up time of 55.2 months. &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; There was a female predominance, with 197 female (60.2%) and 130 male patients (39.8%, female-to-male ratio 1.5). The mean age was comparable between female and male patients (61.2 vs. 61.7 years, p = 0.777). Female patients less frequently had gastric MALT lymphoma (31.5 vs. 39.2%), but this was not statistically significant (p = 0.149). Extragastric manifestations were equally distributed, except for parotid (p = 0.003) and breast lymphoma (n = 8, 100% female) showing a female predominance. This was most likely related to a higher rate of active autoimmune disorders in women (35.6 vs. 11.0%, p &lt; 0.001). \u03b2&lt;sub&gt;2&lt;\/sub&gt;-Microglobulin elevation at diagnosis occurred more often in female patients (42.8 vs. 26.0%; p = 0.008). However, this did not translate into a worse progression-free survival for female (56.0 months, 95% CI 30.1-81.9) versus male patients (49.0 months, 95% CI 25.4-72.5, p = 0.433). Overall survival did not differ between groups. &lt;b&gt;&lt;i&gt;Conclusion:&lt;\/i&gt;&lt;\/b&gt; Our data show surprisingly little differences between female and male patients with MALT lymphoma. Both sexes appeared to have well-balanced clinical features and an identical prognosis.<\/jats:p>","DOI":"10.1159\/000448218","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T21:01:24Z","timestamp":1471899684000},"page":"243-250","source":"Crossref","is-referenced-by-count":9,"title":["Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?"],"prefix":"10.1159","volume":"91","author":[{"given":"Barbara","family":"Kiesewetter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Dolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Simonitsch-Klupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius E.","family":"Mayerhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.19.1561"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2006.15.1123"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342020-00001"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10172"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23638"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.suppl_3.iii19"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1409"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709050889"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1279"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm529"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-3-285"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2298-3"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104004"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2042-z"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12078"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2243"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i17.5167"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1586\/ers.09.54"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-011-0709-9"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2012.00268"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn119"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008135"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21533"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9210-5"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v3.i3.80"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119974"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24287"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-006-0347-9"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.125344"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-517037"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.059246"}],"container-title":["Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/448218","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/448218","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/448218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:01:18Z","timestamp":1745427678000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000448218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,11,9]]}},"URL":"https:\/\/doi.org\/10.1159\/000448218","archive":["Portico"],"relation":{},"ISSN":["0030-2414","1423-0232"],"issn-type":[{"value":"0030-2414","type":"print"},{"value":"1423-0232","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}